Document Detail

Latanoprost-related transient incontinence.
MedLine Citation:
PMID:  17539800     Owner:  NLM     Status:  MEDLINE    
Latanoprost has increasingly become the first choice in topical anti-glaucoma therapy. Local adverse events like hypertrichosis and increased iris pigmentation are common whereas systemic adverse events have been rare and mild in intensity. The authors would like to report a case of transient urge incontinence after initiation of latanoprost therapy confirmed by challenge-rechallenge tests and speculate on the causal relationship.
Vignesh Raja; Pravin Sandanshiv; Muhammad Asghar; Brendan Moriarty
Publication Detail:
Type:  Case Reports; Letter    
Journal Detail:
Title:  Clinical & experimental ophthalmology     Volume:  35     ISSN:  1442-6404     ISO Abbreviation:  Clin. Experiment. Ophthalmol.     Publication Date:    2007 May-Jun
Date Detail:
Created Date:  2007-06-01     Completed Date:  2007-07-24     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100896531     Medline TA:  Clin Experiment Ophthalmol     Country:  Australia    
Other Details:
Languages:  eng     Pagination:  389-90     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antihypertensive Agents / adverse effects*
Glaucoma, Open-Angle / drug therapy*
Intraocular Pressure / drug effects
Middle Aged
Prostaglandins F, Synthetic / adverse effects*
Urinary Incontinence, Urge / chemically induced*
Reg. No./Substance:
0/Antihypertensive Agents; 0/Prostaglandins F, Synthetic; 130209-82-4/latanoprost

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Binocular membranous cataract associated with binocular retinal detachment.
Next Document:  Possible inhibitory effect of oral zinc supplementation on hepatic fibrosis through downregulation o...